Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Exploring Drug Delivery to the Peritoneum
| Exploring Drug Delivery to the Peritoneum |
| Autore | Shegokar Ranjita |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing AG, , 2024 |
| Descrizione fisica | 1 online resource (244 pages) |
| Disciplina | 616.38061 |
| Soggetto topico |
Peritoneum
Peritoneal Cavity Drug Delivery Systems Nanoparticle Drug Delivery System |
| ISBN | 3-031-31694-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Acknowledgments -- Contents -- Peritoneal Organ-Anatomical and Physiological Considerations -- 1 Introduction -- 1.1 Developmental Considerations -- 1.2 Extraperitoneal Tissue -- 1.3 Anatomy of the Peritoneum -- 1.4 Peritoneal Cavity and Recesses -- 1.5 Physiology of Peritoneal Fluid -- 1.6 Splanchnic Circulation: Blood Supply, Venous Drainage, and Lymphatic Drainage -- 1.7 Innervation -- 1.8 Functional Correlations -- 1.9 Peritoneum in Herniorrhaphy -- 1.10 Peritonitis -- 1.11 Peritoneal Dialysis -- 2 Conclusion -- References -- Intraperitoneal Delivery Systems -- 1 Introduction -- 2 History of Intraperitoneal Delivery Systems -- 3 Principles of Intraperitoneal Delivery Systems -- 3.1 Criteria of Intraperitoneal Drug Delivery Systems -- 4 Methods of Intraperitoneal Delivery (IPD) -- 4.1 Direct Injection/Conventional IP Drug Delivery -- 4.2 Continuous Infusion/Implantable IP Drug Delivery Systems -- 5 Drugs for Intraperitoneal Delivery Systems -- 6 Conclusion -- References -- Liposomes and Lipid Nanoparticles as Peritoneal Drug Delivery Systems -- 1 Introduction -- 2 Anatomy and Physiology of the Peritoneum -- 3 Plura and Peritoneal Drug Delivery Systems -- 4 Lipid-Based Nanoparticles as Peritoneal Drug Delivery: Status and Advances -- 5 Different Types of Liposomes and Lipid Nanoparticles -- 5.1 Liposomes -- 5.2 Solid Lipid Nanoparticles -- 5.3 Nanostructured Lipid Carriers -- 5.4 Nanoemulsions -- 5.5 Exosomes -- 5.6 Lipid Polymer Hybrid Nanoparticles -- 6 Lipid-Drug Conjugate -- 7 Peritoneal Targeting by Nanocarriers -- 8 Cell and Molecular Biology of Peritoneal Drug Delivery -- 9 Clinical Status -- 10 Conclusion -- References -- Nano- and Micromedicines as Intraperitoneal Therapy in Ovarian Cancer: Critical Overview and Focus on Pharmaceutical Manufacturing Under cGMP -- 1 Introduction.
1.1 Ovaries: Anatomy, Physiology, and Carcinogenesis -- 1.2 Diagnosis and Epidemiology -- 2 State-of-the-art of Ovarian Cancer Therapies -- 3 Intraperitoneal Route: Characteristics -- 4 Innovative Therapeutic and Diagnostic Tools -- 4.1 Nano- and Microparticles for Intraperitoneal Ovarian Cancer Treatment -- 4.2 Efforts on Nano- and Microparticles Nanomanufacturing -- 5 Conclusion -- References -- Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC): Promising Strides from India -- 1 Introduction -- 2 The Burden of Peritoneal Surface Malignancy -- 3 The Evolution of Peritoneal Surface Oncology in India -- 4 Evidence from India Regarding PIPAC -- 4.1 The Initial Experiences -- 4.2 Drug Safety and Efficacy Studies -- 4.3 PIPAC for Ovarian Origin PM -- 4.4 PIPAC for Appendicular Origin PM -- 4.5 PIPAC for Colorectal Origin PM -- 4.6 PIPAC for Gastric Origin PM -- 5 The Indian Healthcare Structure and Its Influence on PIPAC -- 5.1 Treatment Costs -- 5.2 Referral Patterns and Patient Attitudes -- 6 Adaptation of PIPAC Among Clinicians -- 7 Technological Limitations of PIPAC -- 8 Future Directions -- 9 Conclusion -- References -- HIPEC: Concept and Fundamentals in Colorectal Cancer Peritoneal Metastasis Treatment -- 1 Introduction -- 2 Peritoneal Cancer Index -- 3 Eindhoven Index Regimens -- 4 HIPEC Contraindications -- 5 HIPEC Mechanisms and Role of the Temperature -- 6 Types of HIPEC -- 7 HIPEC Procedure -- 8 1st Stage of a HIPEC Procedure -- 9 2nd Stage of a HIPEC Procedure -- 10 3rd Stage of a HIPEC Procedure -- 11 Last Stage of a HIPEC Procedure -- 12 Final Assessment of Classic HIPEC for Colorectal Cancer Peritoneal Metastasis -- 13 Futuristic Electro - HIPEC -- 14 Conclusion -- References -- Peritoneal Implants and Drug Delivery -- 1 Introduction -- 2 Physiological and Anatomical Considerations -- 3 Permeation Through Peritoneal Membrane. 4 Drug Delivery Implants -- 4.1 Intraperitoneal Injection -- 4.2 Nanocarriers -- 4.3 Liposomes -- 4.4 Hydrogels -- 4.5 Nanofibers -- 4.6 3D Printed Thermosensitive Disks and Thermosensitive Sol-Gels -- 4.7 Nanotextiles -- 5 Methodologies for Evaluating Peritoneal Depots -- 5.1 Particle Size and Entrapment Efficiency -- 5.2 In Vitro Drug Release -- 5.3 Permeation Studies -- 5.4 Microscopy -- 5.5 Fluorescent Testing -- 5.6 Peritoneal Concentration and Pharmacokinetic Estimation -- 6 Peritoneal Depot Portal as Therapeutic Alternative -- 7 Conclusion -- References -- Importance of Computational Models in the Development of Intraperitoneal Administration-Based Drug Delivery Systems for Solid Tumors -- 1 Introduction -- 2 Transport Mechanisms in IP Drug Delivery -- 3 Different Barriers against IP Delivery -- 4 Computational Models -- 4.1 Compartment Models -- 4.2 Spatiotemporal Distribution Models -- 4.2.1 Interstitial Fluid Flow -- 4.2.2 Mass Transport -- 4.2.3 Geometry -- 4.3 Cell-Based Model -- 5 Nanoparticles in Intraperitoneal Chemotherapy -- 5.1 Magnetic Nanoparticle-Based IP Chemotherapy -- 5.2 Thermosensitive Liposome-Mediated IP Chemotherapy -- 6 Discussion and Concluding Remarks -- Abbreviations -- References -- Drug Delivery Systems to the Peritoneum: Current Status and Future Perspectives -- 1 Drug Delivery: Overview -- 2 Anatomy of Peritoneal Cavity and Membrane -- 3 Malignancies in Peritoneal Cavity and Current Therapy -- 4 Intraperitoneal Drug Administration -- 5 Types of Peritoneal Drug Delivery Systems -- 5.1 Microspheres -- 5.2 Nanoparticles -- 5.3 Liposomes -- 5.4 Micelles -- 5.5 Injectable System -- 5.6 Implantable System -- 6 Preclinical Studies -- 6.1 In-Vitro Model -- 6.2 In-Vivo Animal Model -- 6.3 Human Clinical Studies -- 7 Toxicity -- 8 Regulatory Guidelines -- 8.1 Material and Manufacturing -- 8.2 Safety -- 8.3 Efficacy. 8.4 Pharmacokinetic-Pharmacodynamic Correlation -- 9 Pharmacokinetic of Peritoneal Drug Delivery -- 10 Advantages of Peritoneal Drug Delivery -- 11 Future Perspectives on IP Drug Delivery Systems -- 12 Conclusion -- References -- Exploring the Intraperitoneal Route in a New Way for Preclinical Testing -- 1 Introduction -- 2 History of IP Drug Delivery -- 3 The Peritoneum: Anatomy and Histophysiology -- 4 Circulation Dynamics of Peritoneum -- 5 Gross and Histopathology of Peritoneum -- 6 Pharmacokinetics of the Drug Given Intraperitoneally -- 7 Factors Influencing Preclinical IP Route Drug Delivery -- 7.1 The Type of Drugs Used -- 7.2 The Dose of Drug Used -- 7.3 The Volume of Drug -- 7.4 Intra-abdominal Pressure -- 7.5 Hyperthermia -- 7.6 Vehicle Used -- 7.7 Type of Carrier Solutions (Hydrophilic vs Lipophilic) -- 8 Animal Models of IP Drug Delivery -- 9 Conclusion -- References -- Index. |
| Record Nr. | UNINA-9910767503803321 |
Shegokar Ranjita
|
||
| Cham : , : Springer International Publishing AG, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Infectious Diseases Drug Delivery Systems / / edited by Ranjita Shegokar, Yashwant Pathak
| Infectious Diseases Drug Delivery Systems / / edited by Ranjita Shegokar, Yashwant Pathak |
| Autore | Shegokar Ranjita |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (437 pages) |
| Disciplina | 616.90461 |
| Altri autori (Persone) | PathakYashwant |
| Soggetto topico |
Drug delivery systems
Diseases Pharmacology Epidemiology Pharmaceutical chemistry Drug Delivery Pharmaceutics |
| Soggetto non controllato |
Internal Medicine
Medical |
| ISBN |
9783031205217
9783031205200 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | New drugs in synthesis research for Malaria -- New drugs in synthesis research for TB -- New drugs in synthesis viral -- Nanotechnology in Malaria diagnosis -- Nanotechnology in TB diagnosis -- Nanotechnology based vaccination Malaria -- Nanotechnology based vaccination TB -- Disease models in Malaria research -- Disease models in TB research -- Disease models in Viral research -- Viral diseases- cellular understanding of disease : Vaccine development -- Pneumonia- infection -- bacterial pnuemonia -- Lipid based DDS in pneumonia -- hepatitis -- Recent Developments in the Treatment of Bacterial Meningitis -- Bacterial Urinary Tract Infections -- E.coli. |
| Record Nr. | UNINA-9910726284803321 |
|
Shegokar Ranjita
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||